Gustave Roussy, Cancer Campus, Grand Paris: Clinical Trials & FDA Approval Profile
Gustave Roussy, Cancer Campus, Grand Paris (Global / Institutional) sponsors 52 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 38 active protocols (25 recruiting now), 4 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.